IGM Biosciences (IGMS) PT Lowered to $90 at RBC Capital
Tweet
Share
E-mailGet Alerts IGMS Hot Sheet
Price: $1.27 --0%
Rating Summary:
3 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Rating Summary:
3 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 25
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on IGM Biosciences (NASDAQ: IGMS) to $90.00 (from $110.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Coinbase (COIN) PT Raised to $212 at Cantor Fitzgerald
- Five9, Inc (FIVN) PT Raised to $40 at Truist Securities
- Airbnb Inc. (ABNB) PT Raised to $220 at DA Davidson on 'Experiences' Momentum
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
